Patents by Inventor Stephanie Hennen

Stephanie Hennen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • QUINOXALINE DERIVATIVES
    Publication number: 20220396578
    Abstract: The present invention relates to compounds according to general formula (I) which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.
    Type: Application
    Filed: July 18, 2022
    Publication date: December 15, 2022
    Applicant: GRUENENTHAL GMBH
    Inventors: Jo ALEN, Florian JAKOB, Sebastian KRUEGER, Daniela FRIEBE, Stephanie HENNEN
  • QUINOXALINE DERIVATIVES
    Publication number: 20220372041
    Abstract: The present invention relates to compounds according to general formula (I) which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.
    Type: Application
    Filed: July 18, 2022
    Publication date: November 24, 2022
    Applicant: GRUENENTHAL GMBH
    Inventors: Jo ALEN, Florian JAKOB, Sebastian KRUEGER, Philipp BARBIE, Daniela FRIEBE, Stephanie HENNEN
  • SUBSTITUTED PYRROLIDINE AMIDES II
    Publication number: 20220127264
    Abstract: The invention relates to compounds according to general formula (I), which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.
    Type: Application
    Filed: January 5, 2022
    Publication date: April 28, 2022
    Applicant: GRUENENTHAL GMBH
    Inventors: Florian JAKOB, Jo Alen, Sebastian Krueger, Markus Schade, Daniela Friebe, Stephanie Hennen
  • SUBSTITUTED PYRROLIDINE AMIDES IV
    Publication number: 20220106295
    Abstract: The invention relates to compounds according to general formula (I), which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.
    Type: Application
    Filed: December 17, 2021
    Publication date: April 7, 2022
    Applicant: GRUENENTHAL GMBH
    Inventors: Florian JAKOB, Jo ALEN, Sebastian KRUEGER, Daniela FRIEBE, Stephanie HENNEN
  • SUBSTITUTED PYRROLIDINE AMIDES III
    Publication number: 20220089573
    Abstract: The invention relates to compounds according to general formula (I), which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.
    Type: Application
    Filed: January 13, 2020
    Publication date: March 24, 2022
    Applicant: GRÜNENTHAL GMBH
    Inventors: Florian JAKOB, Jo ALEN, Sebastian KRÜGER, Daniela FRIEBE, Stephanie HENNEN, Philipp BARBIE
  • SUBSTITUTED PYRROLIDINE AMIDES III
    Publication number: 20200223840
    Abstract: The invention relates to compounds according to general formula (I), which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.
    Type: Application
    Filed: January 13, 2020
    Publication date: July 16, 2020
    Applicant: GRUENENTHAL GMBH
    Inventors: Florian JAKOB, Jo ALEN, Sebastian KRÜGER, Daniela FRIEBE, Stephanie HENNEN, Philipp BARBIE
  • Substituted pyrrolidine amides I
    Patent number: 10626106
    Abstract: The invention relates to compounds according to general formula (I), which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.
    Type: Grant
    Filed: December 18, 2018
    Date of Patent: April 21, 2020
    Assignee: GRUENENTHAL GMBH
    Inventors: Florian Jakob, Jo Alen, Sebastian Krüger, Markus Schade, Daniela Friebe, Stephanie Hennen
  • Substituted Pyrrolidine Amides I
    Publication number: 20190185455
    Abstract: The invention relates to compounds according to general formula (I), which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.
    Type: Application
    Filed: December 18, 2018
    Publication date: June 20, 2019
    Inventors: Florian JAKOB, Jo ALEN, Sebastian KRÜGER, Markus SCHADE, Daniela FRIEBE, Stephanie HENNEN
  • Substituted Pyrrolidine Amides II
    Publication number: 20190185470
    Abstract: The invention relates to compounds according to general formula (I), which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.
    Type: Application
    Filed: December 18, 2018
    Publication date: June 20, 2019
    Inventors: Florian JAKOB, Jo ALEN, Sebastian KRÜGER, Markus SCHADE, Daniela FRIEBE, Stephanie HENNEN
  • GPR 17 agonists and screening assay
    Patent number: 8623593
    Abstract: The present invention is related to a method of determining a test compound's ability to modify the biological activity of a GPR17. Said method comprises, among others, the step of contacting the test compound with a GPR17, or a functional GPR17 fragment in the presence of a suitable amount of a GPR17 agonist of formula I.
    Type: Grant
    Filed: March 4, 2013
    Date of Patent: January 7, 2014
    Assignee: Rheinische Friedrich-Wilhelms-Universität Bonn
    Inventors: Evi Kostenis, Andreas Spinrath, Stephanie Hennen, Lucas Peters, Christa E. Muller, Rhalid Akkari, Younis Baqi, Kirsten Ritter
  • GPR 17 AGONISTS AND SCREENING ASSAY
    Publication number: 20130338374
    Abstract: The present invention is related to a method of determining a test compound's ability to modify the biological activity of a GPR17. Said method comprises, among others, the step of contacting the test compound with a GPR17, or a functional GPR17 fragment in the presence of a suitable amount of a GPR17 agonist of formula I.
    Type: Application
    Filed: March 4, 2013
    Publication date: December 19, 2013
    Applicant: RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN
    Inventors: Evi Kostenis, Andreas Spinrath, Stephanie Hennen, Lucas Peters, Christa E. Muller, Rhalid Akkari, Younis Baqi, Kirsten Ritter
  • Methods of identifying modulators of GPR17
    Patent number: 8404436
    Abstract: The present invention is related to a method of determining a test compound's ability to modify the biological activity of a GPR17. Said method comprises, among others, the step of contacting the test compound with a GPR17, or a functional GPR17 fragment in the presence of a suitable amount of a GPR17 agonist of formula I.
    Type: Grant
    Filed: February 28, 2012
    Date of Patent: March 26, 2013
    Assignee: Rheinische Friedrich-Wilhelms-Universitat Bonn
    Inventors: Evi Kostenis, Andreas Spinrath, Stephanie Hennen, Lucas Peters, Christa E. Muller, Rhalid Akkari, Younis Baqi, Kirsten Ritter
  • METHODS OF IDENTIFYING MODULATORS OF GPR17
    Publication number: 20130059899
    Abstract: The present invention is related to a method of determining a test compound's ability to modify the biological activity of a GPR17. Said method comprises, among others, the step of contacting the test compound with a GPR17, or a functional GPR17 fragment in the presence of a suitable amount of a GPR17 agonist of formula I.
    Type: Application
    Filed: February 28, 2012
    Publication date: March 7, 2013
    Applicant: RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITAT BONN
    Inventors: Evi Kostenis, Andreas Spinrath, Stephanie Hennen, Lucas Peters, Christa E. Müller, Rhalid Akkari, Younis Baqi, Kirsten Ritter